Home
>
National Drug Code (NDC)
>
Leukine
Leukine - 0024-5844-05 - (SARGRAMOSTIM)
Drug Information of Leukine
| Product NDC: | 0024-5844 |
| Proprietary Name: | Leukine |
| Non Proprietary Name: | SARGRAMOSTIM |
| Active Ingredient(s): | 500 ug/mL & nbsp; SARGRAMOSTIM |
| Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Leukine
| Product NDC: | 0024-5844 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103362 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19961201 |
Package Information of Leukine
| Package NDC: | 0024-5844-05 |
| Package Description: | 5 VIAL in 1 CARTON (0024-5844-05) > 1 mL in 1 VIAL |
NDC Information of Leukine
| NDC Code | 0024-5844-05 |
| Proprietary Name | Leukine |
| Package Description | 5 VIAL in 1 CARTON (0024-5844-05) > 1 mL in 1 VIAL |
| Product NDC | 0024-5844 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | SARGRAMOSTIM |
| Dosage Form Name | LIQUID |
| Route Name | INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 19961201 |
| Marketing Category Name | BLA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | SARGRAMOSTIM |
| Strength Number | 500 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] |
